Atreca Inc BCEL

Alternate Symbol(s): COLUF

Atreca, Inc. is a clinical-stage biopharmaceutical company. The Company is discovering and developing antibody-based therapeutics to treat a range of solid tumor types. Its most advanced product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. ATRC-101 reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal and breast cancer samples from multiple patients. It commenced clinical development of ATRC-101 with a Phase Ib clinical trial evaluating ATRC-101 as a monotherapy in patients with select solid tumors and opens a new cohort to evaluate ATRC-101 in combination with pembrolizumab, a PD-1 checkpoint inhibitor. It is also advancing additional product candidates using its discovery platform. Its oncology programs include APN-497444, an ADC against a tumor glycan target, and APN-346958, a CD3 bispecific T-cell engager against an RNA-binding protein target.

PINL:BCEL - Post by User

Atreca Inc

Bullboard Posts

Comment by sweatmanon May 28, 2013 10:40am

235 Views

Post# 21449705

RE: RE: RE: RE: RE: RE: RE: RE: RE: Institutional

There are shadow bankers who could very well find the framework for lots of love here...and to hack a phrase from one of America's most recognizable, albeit not the most eloquent of politicians without a teleprompter...'here is no here, here'. In othe words, CSI may look like a good play, but at a (much) lower price. I am thinking around the $1.20 range, give or take a few pennies. At a $1.55 it is (imo) a frothy price. With the recent posting in the FP, I would suspect that part of the terms have to do with getting the word out. So brace yourself for the usual three or four writers, a couple of pieces in the FP and the Globe...all singing the praises of the company that has...a lake?

Bullboard Posts

Red Light Holland and Costco Canada partner on mushroom kits